Published in Cancer Causes Control on September 01, 2006
Aspirin intake and survival after breast cancer. J Clin Oncol (2010) 4.50
The role of aspirin in cancer prevention. Nat Rev Clin Oncol (2012) 2.94
Cardiotoxicity of anticancer drugs: the need for cardio-oncology and cardio-oncological prevention. J Natl Cancer Inst (2009) 2.55
Contemporary epidemiology of renal cell cancer. Cancer J (2008) 2.40
Prospective evaluation of analgesic use and risk of renal cell cancer. Arch Intern Med (2011) 2.34
Use of aspirin, other nonsteroidal anti-inflammatory drugs, and acetaminophen and postmenopausal breast cancer incidence. J Clin Oncol (2012) 1.85
Aspirin and cancer: has aspirin been overlooked as an adjuvant therapy? Br J Cancer (2011) 1.76
Nonsteroidal anti-inflammatory drugs and breast cancer risk in the National Institutes of Health-AARP Diet and Health Study. Breast Cancer Res (2008) 1.52
Cyclooxygenase-2 and cancer treatment: understanding the risk should be worth the reward. Clin Cancer Res (2010) 1.44
Prostaglandin E2 EP receptors as therapeutic targets in breast cancer. Cancer Metastasis Rev (2011) 1.21
Analgesic use and sex steroid hormone concentrations in postmenopausal women. Cancer Epidemiol Biomarkers Prev (2010) 1.20
Nonsteroidal anti-inflammatory drugs and risk for ovarian and endometrial cancers in the Iowa Women's Health Study. Cancer Epidemiol Biomarkers Prev (2010) 1.13
Inverse association of NSAID use and ovarian cancer in relation to oral contraceptive use and parity. Br J Cancer (2008) 1.09
Platelets and cancer: a casual or causal relationship: revisited. Cancer Metastasis Rev (2014) 1.07
Use of nonsteroidal antiinflammatory agents and incidence of ovarian cancer in 2 large prospective cohorts. Am J Epidemiol (2009) 1.05
Aspirin and lung cancer risk in a cohort study of women: dosage, duration and latency. Br J Cancer (2007) 1.04
Dose-risk and duration-risk relationships between aspirin and colorectal cancer: a meta-analysis of published cohort studies. PLoS One (2013) 1.01
Emerging roles of the microbiome in cancer. Carcinogenesis (2013) 1.00
Aspirin and urologic cancer risk: an update. Nat Rev Urol (2012) 0.91
No association between cyclooxygenase-2 and uridine diphosphate glucuronosyltransferase 1A6 genetic polymorphisms and colon cancer risk. World J Gastroenterol (2009) 0.89
Non-steroidal anti-inflammatory drugs and cancer incidence by sex in the VITamins And Lifestyle (VITAL) cohort. Cancer Causes Control (2012) 0.86
Regular aspirin use and breast cancer risk in US Black women. Cancer Causes Control (2011) 0.85
Modulation of breast cancer risk by nonsteroidal anti-inflammatory drugs. J Natl Cancer Inst (2008) 0.84
C-reactive protein genotypes and haplotypes, polymorphisms in NSAID-metabolizing enzymes, and risk of colorectal polyps. Pharmacogenet Genomics (2009) 0.83
Non-steroidal anti-inflammatory drugs use is associated with reduced risk of inflammation-associated cancers: NIH-AARP study. PLoS One (2014) 0.82
Decreased risk of squamous cell carcinoma of the head and neck in users of nonsteroidal anti-inflammatory drugs. Int J Otolaryngol (2010) 0.82
Nuclear factor-erythroid 2-related factor 2 as a chemopreventive target in colorectal cancer. Expert Opin Ther Targets (2011) 0.82
Analgesic use in relation to sex hormone and prolactin concentrations in premenopausal women. Cancer Causes Control (2013) 0.82
Analgesic use and patterns of estrogen metabolism in premenopausal women. Horm Cancer (2014) 0.78
Epidemiological study of prostate cancer (EPICAP): a population-based case-control study in France. BMC Cancer (2014) 0.77
Aspirin and age related macular degeneration; the possible relationship. Med Hypothesis Discov Innov Ophthalmol (2013) 0.76
Analgesic use during pregnancy and risk of infant leukaemia: a Children's Oncology Group study. Br J Cancer (2010) 0.76
The biological complexity of colorectal cancer: insights into biomarkers for early detection and personalized care. Therap Adv Gastroenterol (2016) 0.75
Disparities in breast cancer mortality trends between 30 European countries: retrospective trend analysis of WHO mortality database. BMJ (2010) 7.00
A meta-analysis of alcohol consumption and the risk of 15 diseases. Prev Med (2004) 6.24
Aspirin and non-steroidal anti-inflammatory drugs for cancer prevention: an international consensus statement. Lancet Oncol (2009) 5.05
Alcohol drinking in never users of tobacco, cigarette smoking in never drinkers, and the risk of head and neck cancer: pooled analysis in the International Head and Neck Cancer Epidemiology Consortium. J Natl Cancer Inst (2007) 4.55
Epidemiology and risk factors of urothelial bladder cancer. Eur Urol (2012) 4.45
Risk factors for falls in community-dwelling older people: a systematic review and meta-analysis. Epidemiology (2010) 3.86
Autoimmune disorders and risk of non-Hodgkin lymphoma subtypes: a pooled analysis within the InterLymph Consortium. Blood (2008) 3.81
Recent patterns in gastric cancer: a global overview. Int J Cancer (2009) 3.75
False-positive results in cancer epidemiology: a plea for epistemological modesty. J Natl Cancer Inst (2008) 3.72
Interaction between tobacco and alcohol use and the risk of head and neck cancer: pooled analysis in the International Head and Neck Cancer Epidemiology Consortium. Cancer Epidemiol Biomarkers Prev (2009) 3.33
Gallbladder cancer worldwide: geographical distribution and risk factors. Int J Cancer (2006) 3.27
Coffee drinking and hepatocellular carcinoma risk: a meta-analysis. Hepatology (2007) 3.22
Cigarette smoking, body mass index, and stressful life events as risk factors for psoriasis: results from an Italian case-control study. J Invest Dermatol (2005) 3.18
Smoking in Italy 2005-2006: effects of a comprehensive National Tobacco Regulation. Prev Med (2007) 2.61
Clinical utility of a plasma-based miRNA signature classifier within computed tomography lung cancer screening: a correlative MILD trial study. J Clin Oncol (2014) 2.57
Dietary zinc and prostate cancer risk: a case-control study from Italy. Eur Urol (2007) 2.41
A further plea for adherence to the principles underlying science in general and the epidemiologic enterprise in particular. Int J Epidemiol (2009) 2.35
Risk of prostate, breast and colorectal cancer after skin cancer diagnosis. Int J Cancer (2008) 2.28
Risk factors for thyroid cancer: an epidemiological review focused on nutritional factors. Cancer Causes Control (2008) 2.17
Worldwide mortality from cirrhosis: an update to 2002. J Hepatol (2007) 2.16
Vinyl chloride exposure and cirrhosis: a systematic review and meta-analysis. Dig Liver Dis (2012) 2.15
Mechanisms of disease: The epidemiology of bladder cancer. Nat Clin Pract Urol (2006) 2.13
Trends in mortality from hepatocellular carcinoma in Europe, 1980-2004. Hepatology (2008) 2.11
Epidemiology and aetiology of gestational trophoblastic diseases. Lancet Oncol (2003) 2.03
Non-Hodgkin lymphoma and obesity: a pooled analysis from the InterLymph Consortium. Int J Cancer (2008) 2.01
The burden of cancer attributable to alcohol drinking. Int J Cancer (2006) 2.01
Ovarian cancer in Europe: Cross-sectional trends in incidence and mortality in 28 countries, 1953-2000. Int J Cancer (2005) 1.98
Relation of dietary glycemic load with ischemic and hemorrhagic stroke: a cohort study in Greece and a meta-analysis. Eur J Nutr (2014) 1.98
Total exposure and exposure rate effects for alcohol and smoking and risk of head and neck cancer: a pooled analysis of case-control studies. Am J Epidemiol (2009) 1.97
Time from adenosine di-phosphate receptor antagonist discontinuation to coronary bypass surgery in patients with acute coronary syndrome: meta-analysis and meta-regression. Int J Cardiol (2013) 1.94
Mortality from cardiovascular and cerebrovascular diseases in Europe and other areas of the world: an update. Eur J Cardiovasc Prev Rehabil (2009) 1.90
Coffee reduces risk for hepatocellular carcinoma: an updated meta-analysis. Clin Gastroenterol Hepatol (2013) 1.87
Cigarette smoking and risk of non-Hodgkin lymphoma: a pooled analysis from the International Lymphoma Epidemiology Consortium (interlymph). Cancer Epidemiol Biomarkers Prev (2005) 1.87
Circulating adiponectin and endometrial cancer risk. J Clin Endocrinol Metab (2004) 1.86
Trends in mortality from urologic cancers in Europe, 1970-2008. Eur Urol (2011) 1.85
Annual or biennial CT screening versus observation in heavy smokers: 5-year results of the MILD trial. Eur J Cancer Prev (2012) 1.82
Liver cancer: descriptive epidemiology and risk factors other than HBV and HCV infection. Cancer Lett (2008) 1.80
Cancer risk associated with alcohol and tobacco use: focus on upper aero-digestive tract and liver. Alcohol Res Health (2006) 1.80
Cancer risk associated with use of metformin and sulfonylurea in type 2 diabetes: a meta-analysis. Oncologist (2012) 1.79
Trends in oesophageal cancer incidence and mortality in Europe. Int J Cancer (2008) 1.78
Cigarette, cigar, and pipe smoking and the risk of head and neck cancers: pooled analysis in the International Head and Neck Cancer Epidemiology Consortium. Am J Epidemiol (2013) 1.73
Dietary folate and risk of prostate cancer in Italy. Cancer Epidemiol Biomarkers Prev (2005) 1.72
Coffee and tea intake and risk of oral, pharyngeal and esophageal cancer. Oral Oncol (2003) 1.67
Coffee and tea intake and risk of head and neck cancer: pooled analysis in the international head and neck cancer epidemiology consortium. Cancer Epidemiol Biomarkers Prev (2010) 1.63
Mouthwash and oral cancer risk quantitative meta-analysis of epidemiologic studies. Ann Agric Environ Med (2012) 1.62
Risk factors for oral and pharyngeal cancer in young adults. Oral Oncol (2004) 1.62
Relationship and prognostic value of modified coronary artery calcium score, FEV1, and emphysema in lung cancer screening population: the MILD trial. Radiology (2011) 1.61
Food groups and renal cell carcinoma: a case-control study from Italy. Int J Cancer (2007) 1.60
Temporal changes of under-reporting of cigarette consumption in population-based studies. Tob Control (2010) 1.58
Fried potatoes and human cancer. Int J Cancer (2003) 1.58
Nutrient-based dietary patterns and the risk of oral and pharyngeal cancer. Oral Oncol (2010) 1.58
A catalyst for change: the European cancer Patient's Bill of Rights. Oncologist (2014) 1.55
Influence of the Mediterranean diet on the risk of cancers of the upper aerodigestive tract. Cancer Epidemiol Biomarkers Prev (2003) 1.55
Number of nevi at a specific anatomical site and its relation to cutaneous malignant melanoma. J Invest Dermatol (2006) 1.52
Intake of selected micronutrients and the risk of surgically treated benign prostatic hyperplasia: a case-control study from Italy. Eur Urol (2005) 1.51
Alcohol and tobacco use, and cancer risk for upper aerodigestive tract and liver. Eur J Cancer Prev (2008) 1.51
Monitoring the decrease in breast cancer mortality in Europe. Eur J Cancer Prev (2005) 1.50
Declining mortality from bladder cancer in Europe. BJU Int (2007) 1.49
The changing pattern of kidney cancer incidence and mortality in Europe. BJU Int (2008) 1.49
Hepatitis viruses, alcohol, and tobacco in the etiology of hepatocellular carcinoma in Italy. Cancer Epidemiol Biomarkers Prev (2006) 1.47
Epidemiology and pathophysiology of alcohol and breast cancer: Update 2012. Alcohol Alcohol (2012) 1.47
Enhancing epidemiologic research on head and neck cancer: INHANCE - The international head and neck cancer epidemiology consortium. Oral Oncol (2009) 1.47
Hormone replacement therapy and cancer risk: a systematic analysis from a network of case-control studies. Int J Cancer (2003) 1.46
Atopic disease and risk of non-Hodgkin lymphoma: an InterLymph pooled analysis. Cancer Res (2009) 1.45
A prospective study on survival in cancer patients with and without venous thromboembolism. Intern Emerg Med (2013) 1.42
Recent trends in colorectal cancer mortality in Europe. Int J Cancer (2010) 1.41
Cancer risk for patients using thiazolidinediones for type 2 diabetes: a meta-analysis. Oncologist (2013) 1.41
Glycemic index, glycemic load, and cancer risk: a meta-analysis. Am J Clin Nutr (2008) 1.41
[Tobacco taxation is a public health measure]. Epidemiol Prev (2014) 1.39
Estimates of the incidence and prevalence of renal cell carcinoma in Italy in 2002 and projections for the years 2007 and 2012. Tumori (2009) 1.39
Trends in incidence of various morphologies of malignant melanoma in Vaud and Neuchatel, Switzerland. Melanoma Res (2005) 1.39
Mouthwash use and cancer of the head and neck: a pooled analysis from the International Head and Neck Cancer Epidemiology Consortium. Eur J Cancer Prev (2016) 1.38
Cancer mortality in Europe, 1995-1999, and an overview of trends since 1960. Int J Cancer (2004) 1.38
Pancreatic cancer: overview of descriptive epidemiology. Mol Carcinog (2012) 1.38
Smoking behaviour, involuntary smoking, attitudes towards smoke-free legislations, and tobacco control activities in the European Union. PLoS One (2010) 1.35
Leveling of prostate cancer mortality in Western Europe. Prostate (2004) 1.34
Alcohol drinking and pancreatic cancer risk: a meta-analysis of the dose-risk relation. Int J Cancer (2010) 1.34
Trends in mortality from major cancers in the European Union, including acceding countries, in 2004. Cancer (2004) 1.33
Coffee drinking and endometrial cancer risk: a metaanalysis of observational studies. Am J Obstet Gynecol (2008) 1.32
A pooled analysis of case-control studies of thyroid cancer: cigarette smoking and consumption of alcohol, coffee, and tea. Cancer Causes Control (2003) 1.31
Making prospective registration of observational research a reality. Sci Transl Med (2014) 1.31
Family history of cancer: pooled analysis in the International Head and Neck Cancer Epidemiology Consortium. Int J Cancer (2009) 1.30
Alcohol consumption and cancer risk. Nutr Cancer (2011) 1.30
B-cell non-Hodgkin's lymphoma and hepatitis C virus infection: a systematic review. Int J Cancer (2004) 1.26
Tobacco smoking, smoking cessation, and cumulative risk of upper aerodigestive tract cancers. Am J Epidemiol (2007) 1.25
Cutaneous malignant melanoma in women. Phenotypic characteristics, sun exposure, and hormonal factors: a case-control study from Italy. Ann Epidemiol (2005) 1.24